User Reviews for Idelalisib
Also known as: Zydelig
Idelalisib has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of those users who reviewed Idelalisib reported a positive effect, while 100% reported a negative effect.
|Follicular Lymphoma||1.0||1 reviews||12 medications|
|Summary of Idelalisib reviews||1.0||1 reviews|
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
Zydelig (idelalisib) for Follicular Lymphoma: “After 6-1/2 years (2/2011-9/2017) on Rituxan-based therapy, I became refractory to it. I took 6 months off from all treatment, then started on Zydelig (3/2018). After 2-1/2 months, I experienced increasingly painful stomach and intestinal cramps, then diarrhea which landed me in the local V.A. hospital (6/30/2018-7/15/2018) with 'ballistic diarrhea' and experienced several Atrial Fibrillation events. A month after discharge, I was diagnosed (8/2018) with Type 2 diabetes. In November 2018, I was diagnosed with Myelodysplastic Syndrome after a bone marrow biopsy, and am now monitored with monthly blood-draws and physical exams. [My follicular lymphoma is presumptive evidence of Agent Orange exposure in 1968 in the Mekong Delta, and that is why I pay -0- for my treatments, Rxs and medications.]”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about idelalisib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: PI3K inhibitors
Other brands: Zydelig